An oxidative stress marker
Beta-glucuronidase is an enzyme produced by certain unfriendly gut bacteria.
Beta-glucuronidase is an enzyme produced by various types of bacteria in the gut and plays a key role in gut health. It is involved in the process of deconjugation of glucuronides, which are compounds formed in the liver to help detoxify substances like hormones, toxins, and drugs. Once these glucuronides reach the gut, beta-glucuronidase can break them down, leading to the reabsorption of the substances that were previously detoxified, which can have both beneficial and harmful effects depending on the compounds involved. Beta-glucuronidase activity serves as a biomarker for the bacterial metabolism of toxins, drugs, and endogenous substances like hormones. Elevated levels of this enzyme in the gut can suggest dysbiosis, or an imbalance of gut bacteria. High beta-glucuronidase activity is often linked to increased risk of conditions like colon cancer and hormone-related diseases (such as estrogen dominance), as the enzyme may facilitate the reabsorption of harmful substances that were meant to be excreted. For example, the enzyme can reverse the detoxification of estrogen, leading to higher circulating levels, which can contribute to hormonal imbalances. On the other hand, low beta-glucuronidase activity may indicate suboptimal bacterial activity, potentially pointing to a lack of healthy gut flora or reduced detoxification capacity. This could mean that the gut is not effectively recycling beneficial compounds or clearing toxins. A balanced level of beta-glucuronidase activity is typically associated with a healthy, functioning gut microbiome that maintains a proper balance between detoxification and reabsorption processes.
ß-Hydroxybutyrate is a metabolic marker of blood sugar utilization and insulin function.
ß-Hydroxybutyrate is a metabolic marker of blood sugar utilization and insulin function.
a ketone body
Indicator of biotin deficiency
Indicator of biotin deficiency
Biotin Markers
Ketone formed from acetyl CoA
Elevated Beta-Pregnanediol (b-Pregnanediol) in men's urine signifies an imbalance in progesterone metabolism. Beta-Pregnanediol is a metabolite of progesterone, a hormone that is present in men, albeit at lower levels compared to premenopausal women. Progesterone is primarily produced in the corpus luteum following ovulation in women and to a lesser extent in the adrenal glands of both sexes. In men, it plays a role in the production of testosterone and sperm development. When Beta-Pregnanediol levels are elevated, it indicates an increased metabolism of progesterone through specific pathways. The metabolism of progesterone leads to the production of two isomers of Beta-Pregnanediol, namely 5α-pregnanediol and 5β-pregnanediol. Both Alpha-Pregnanediol and Beta-Pregnanediol are used as surrogate markers since they are the most abundant metabolites of progesterone.
Beta-Pregnanediol is a crucial metabolic byproduct of progesterone, one of the primary female sex hormones. Scientifically, Beta-Pregnanediol is a progesterone metabolite, which means it is formed when the body breaks down progesterone. Its measurement in urine provides valuable insights into the body's progesterone levels. Progesterone plays a vital role in the menstrual cycle, pregnancy, and overall reproductive health. It prepares the uterine lining for implantation of the fertilized egg and maintains pregnancy. Evaluating Beta-Pregnanediol levels is particularly important in assessing luteal phase function, diagnosing luteal phase defects, and monitoring progesterone supplementation in fertility treatments. Abnormal levels can indicate various conditions, including menstrual irregularities, infertility, and hormonal imbalances. The advantage of measuring Beta-Pregnanediol in urine, especially in a comprehensive hormone panel, is that it reflects an integrated measure of hormone production over time, rather than a momentary snapshot, as is the case with blood tests.
Beta-Pregnanediol, when measured in conjunction with oral progesterone supplementation serves as a critical marker for assessing the efficacy and metabolic impact of progesterone therapy. This particular metabolite of progesterone, excreted predominantly in urine, provides insight into the body's utilization and processing of administered progesterone. In the context of hormone replacement therapy or treatment for menstrual irregularities, fertility issues, or menopausal symptoms, monitoring Beta-Pregnanediol levels can be instrumental in determining the appropriate dosing and effectiveness of oral progesterone. Elevated levels of this metabolite post-oral progesterone intake are indicative of adequate absorption and metabolism of the hormone, signifying an effective therapeutic regimen. Conversely, low levels may suggest poor absorption, rapid metabolism, or inadequate dosing, necessitating adjustments in the treatment plan. This marker becomes particularly valuable in managing conditions such as progesterone deficiency, luteal phase defects, or hormone-related mood disorders. The comprehensive hormone panel, through serial urine sampling across the menstrual cycle, offers a dynamic and detailed profile of hormonal fluctuations in response to oral progesterone, thereby facilitating a more tailored and effective treatment approach. Such personalized monitoring is crucial in optimizing hormone therapy, minimizing side effects, and ensuring the best possible outcomes in women’s health management. This approach underscores the importance of precision medicine in hormonal treatments, where individual variations in hormone metabolism and response are taken into account for optimal patient care.
Cholesterol absorption indicator
trimethylglycine / TMG
Betaine, also known as trimethylglycine (TMG), is a naturally occurring nutrient derived primarily from choline and found abundantly in foods such as beets, spinach, and whole grains. It serves as a key methyl donor in the body, supporting the conversion of homocysteine to methionine via the betaine-homocysteine methyltransferase (BHMT) pathway. This makes betaine a crucial participant in the body’s methylation network, working in parallel with folate, vitamin B12, and S-adenosylmethionine (SAM) to maintain cellular, neurological, and cardiovascular health. On the Neurotransmitter XL panel, betaine reflects methylation reserve capacity and the body’s ability to sustain healthy homocysteine metabolism, neurotransmitter regulation, and detoxification processes. Because methylation underlies the production and breakdown of key brain chemicals—including dopamine, serotonin, and adrenaline—betaine is deeply connected to mood, energy, focus, and stress resilience.
associated with metabolic syndrome